CIC
IPSC icon

Cornercap Investment Counsel’s Century Therapeutics IPSC Stock Holding History

Cornercap Investment Counsel’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,978
Closed -$44.4K – 505
2024
Q3 		$44.4K Sell
25,978
-25,037
-49% -$49K 0.01% 510
2024
Q2 		$130K Sell
51,015
-505
-1% -$1.6K 0.02% 566
2024
Q1 		$215K Hold
51,520
– – 0.03% 557
2023
Q4 		$171K Hold
51,520
– – 0.03% 542
2023
Q3 		$103K Sell
51,520
-655
-1% -$1.74K 0.02% 536
2023
Q2 		$165K Hold
52,175
– – 0.03% 531
2023
Q1 		$181K Buy
+52,175
New +$229K 0.03% 509

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cornercap Investment Counsel's IPSC Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Century Therapeutics (IPSC) in Q4 2024, closing a stake of 25,978 shares — an estimated $44.4K sold.

Cornercap Investment Counsel first reported a position in IPSC in Q1 2023 and held it in 7 quarters. The position peaked at $215K in Q1 2024. 72 funds tracked by Wall St. Rank hold IPSC as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Century Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 25,978 Century Therapeutics shares in Q4 2024, an estimated $44.4K.
  • Cornercap Investment Counsel first reported a position in Century Therapeutics in Q1 2023 and held it in 7 quarters.
  • Cornercap Investment Counsel's Century Therapeutics position peaked at $215K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.